Genet Med. 2009 Aug;11(8):577-81.
Personalized medicine and disruptive innovation: implications for technology assessment.
Schulman KA, Vidal AV, Ackerly DC.
Duke Clinical Research Institute, Duke Translational Medicine Institute, Durham, North Carolina, USA. kevin.schulman@duke.edu
PMID: 19606052 [PubMed - in process]